People · Operator
Named in public records as an officer, director or promoter · active 2022–2022 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| UCAN Co | — | Biotechnology | Series A | $21.5M | $119.7M | 2022 |
Jack Herpok at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jack Herpok on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Stephen Squinto | 1 | 8 |
| David Feldman | 1 | 4 |
| Clive Sirkin | 1 | 3 |
| Arthur Chow | 1 | 3 |
| James Greco | 1 | 3 |
| Ramesh Ratan | 1 | 2 |
| Kannankote Srikanth | 1 | 2 |
| Stephen Squinto, Sr. | 1 | 1 |
| Peter Kaufman | 1 | 1 |
| Shoba Murali | 1 | 1 |
| Jonathan Kucinski | 1 | 1 |
| Elena Sukacheva | 1 | 1 |
| Kannankote (Sri) Srikanth | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.